Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats

DMM Disease Models and Mechanisms

Volumn 6, Issue 2, 2013, Pages 457-466

  Donner, Daniel ^a   Headrick, John P ^a   Peart, Jason N ^a   Du Toit, Eugene F ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; LACTATE DEHYDROGENASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; REPERFUSION INJURY; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ANIMALS; BENZAMIDES; CARDIOTONIC AGENTS; DIETARY CARBOHYDRATES; HUMANS; INSULIN; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE; OBESITY; PHOSPHORYLATION; PIPERAZINES; PROTEIN KINASES; RATS; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION; THINNESS;

EID: 84875201324     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010959     Document Type: Article

References (74)

1. Alpert, M. A., Terry, B. E., Lambert, C. R., Kelly, D. L., Panayiotou, H., Mukerji, V., Massey, C. V. and Cohen, M. V. (1993). Factors influencing left ventricular systolic function in nonhypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty. Am. J. Cardiol. 71, 733-737. (Pubitemid 23085827)
2. Arena, R. and Lavie, C. J. (2010). The obesity paradox and outcome in heart failure: is excess bodyweight truly protective? Future Cardiol. 6, 1-6.
3. Aronson, D., Nassar, M., Goldberg, T., Kapeliovich, M., Hammerman, H. and Azzam, Z. S. (2010). The impact of body mass index on clinical outcomes after acute myocardial infarction. Int. J. Cardiol. 145, 476-480.
4. Aubin, M. C., Lajoie, C., Clément, R., Gosselin, H., Calderone, A. and Perrault, L. P. (2008). Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J. Pharmacol. Exp. Ther. 325, 961-968. (Pubitemid 351724317)
5. Aubin, M. C., Cardin, S., Comtois, P., Clément, R., Gosselin, H., Gillis, M. A., Le Quang, K., Nattel, S., Perrault, L. P. and Calderone, A. (2010). A high-fat diet increases risk of ventricular arrhythmia in female rats: enhanced arrhythmic risk in the absence of obesity or hyperlipidemia. J. Appl. Physiol. 108, 933-940.
6. Barbarroja, N., López-Pedrera, R., Mayas, M. D., García-Fuentes, E., Garrido-Sánchez, L., Macías- González, M., El Bekay, R., Vidal-Puig, A. and Tinahones, F. J. (2010). The obese healthy paradox: is inflammation the answer? Biochem. J. 430, 141-149.
7. Bertrand, L., Horman, S., Beauloye, C. and Vanoverschelde, J. L. (2008). Insulin signalling in the heart. Cardiovasc. Res. 79, 238-248. (Pubitemid 351951609)
8. Bouhidel, O., Pons, S., Souktani, R., Zini, R., Berdeaux, A. and Ghaleh, B. (2008). Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am. J. Physiol. Heart Circ. Physiol. 295, H1580-H1586.
9. Bulhak, A. A., Jung, C., Ostenson, C. G., Lundberg, J. O., Sjöquist, P. O. and Pernow J. (2009). PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J. Physiol. Heart Circ. Physiol. 296, H719-H727.
10. Cai, L., Li, W., Wang, G., Guo, L., Jiang, Y. and Kang, Y. J. (2002). Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51, 1938-1948. (Pubitemid 34564309)
11. Champattanachai, V., Marchase, R. B. and Chatham, J. C. (2007). Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am. J. Physiol. Cell. Physiol. 292, C178-C187. (Pubitemid 46115129)
12. Chang, Z., Xiao, Q., Feng, Q. and Yang, Z. (2010). PKB/Akt signaling in heart development and disease. Front. Biosci. (Elite Ed.) E 2, 1485-1491.
13. Chuang, C. C., Bumrungpert, A., Kennedy, A., Overman, A., West, T., Dawson, B. and McIntosh, M. K. (2011). Grape powder extract attenuates tumor necrosis factor a-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J. Nutr. Biochem. 22:89-94.
14. Clark, C., Smith, W., Lochner, A. and Du Toit, E. F. (2011). The effects of gender and obesity on myocardial tolerance to ischemia. Physiol. Res. 60, 291-301.
15. Clavijo, L. C., Pinto, T. L., Kuchulakanti, P. K., Torguson, R., Chu, W. W., Satler, L. F., Kent, K. M., Suddath, W. O., Pichard, A. D. and Waksman, R. (2006). Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc. Revasc. Med. 7, 7-11.
16. Desrois, M., Clarke, K., Lan, C., Dalmasso, C., Cole, M., Portha, B., Cozzone, P. J. and Bernard, M. (2010). Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 299, H1679-H1686.
17. Doehner, W., Erdmann, E., Cairns, R., Clark, A. L., Dormandy, J. A., Ferrannini, E. and Anker, S. D. (2012). Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population. Int. J. Cardiol. 162, 20-26.
18. Dorner, T. E. and Rieder, A. (2012). Obesity paradox in elderly patients with cardiovascular diseases. Int. J. Cardiol. 155, 56-65.
19. Downey, J. M., Davis, A. M. and Cohen, M. V. (2007). Signaling pathways in ischemic preconditioning. Heart Fail. Rev. 12, 181-188. (Pubitemid 350176691)
20. Du Toit, E. F., Nabben, M. and Lochner, A. (2005). A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res. Cardiol. 100, 346-354. (Pubitemid 40974085)
21. Du Toit, E. F., Smith, W., Muller, C., Strijdom, H., Stouthammer, B., Woodiwiss, A. J., Norton, G. R. and Lochner, A. (2008). Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity. Am. J. Physiol. Heart Circ. Physiol. 294, H2336-H2343.
22. Essop, M. F., Anna Chan, W. Y., Valle, A., García-Palmer, F. J. and Du Toit, E. F. (2009). Impaired contractile function and mitochondrial respiratory capacity in response to oxygen deprivation in a rat model of pre-diabetes. Acta Physiol. (Oxf.) 197, 289-296.
23. Ferdinandy, P., Schulz, R. and Baxter, G. F. (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 59, 418-458.
24. Fiordaliso, F., Leri, A., Cesselli, D., Limana, F., Safai, B., Nadal-Ginard, B., Anversa, P. and Kajstura, J. (2001). Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50, 2363-2375. (Pubitemid 33641924)
25. Fryer, R. M., Patel, H. H., Hsu, A. K. and Gross, G. J. (2001). Stress-activated protein kinase phosphorylation during cardioprotection in the ischaemic myocardium. Am. J. Physiol. Heart Circ. Physiol. 81, H1184-H1192.
26. Gao, F., Gao, E., Yue, T. L., Ohlstein, E. H., Lopez, B. L., Christopher, T. A. and Ma, X. L. (2002). Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105, 1497-1502. (Pubitemid 34263284)
27. Girod, W. G., Jones, S. P., Sieber, N., Aw, T. Y. and Lefer, D. J. (1999). Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19, 2776-2781. (Pubitemid 29536057)
28. Gómez-Pérez, Y., Gianotti, M., Proenza, A. M. and Lladó, I. (2011). Age-related decline of skeletal muscle insulin sensitivity in rats: effect of sex and muscle type. Rejuvenation Res. 14, 153-161.
29. Görbe, A., Varga, Z. V., Kupai, K., Bencsik, P., Kocsis, G. F., Csont, T., Boengler, K., Schulz, R. and Ferdinandy, P. (2011). Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. Am. J. Physiol. Heart Circ. Physiol. 300, H1907-H1913.
30. Gross, E. R., Hsu, A. K. and Gross, G. J. (2007a). GSK3β inhibition and K (ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res. Cardiol. 102, 341-349. (Pubitemid 46909713)
31. Gross, E. R., Hsu, A. K. and Gross, G. J. (2007b). Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 56, 127-136.
32. Gu, Z., Du, Y., Liu, Y., Ma, L., Li, L., Gong, Y., Tian, H. and Li, C. (2011). Effect of aging on islet beta-cell function and its mechanisms in Wistar rats. AGE 34, 1393-1403.
33. Halestrap, A. P., Clarke, S. J. and Khaliulin, I. (2007). The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta 1767, 1007-1031. (Pubitemid 47101788)
34. Hall, J. A., French, T. K., Rasmusson, K. D., Vesty, J. C., Roberts, C. A., Rimmasch, H. L., Kfoury, A. G. and Renlund, D. G. (2005). The paradox of obesity in patients with heart failure. J. Am. Acad. Nurse Pract. 17, 542-546.
35. Hausenloy, D. J. and Yellon, D. M. (2009). Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 204, 334-341.
36. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M. and Hotamisligil, G. S. (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333-336. (Pubitemid 35398190)
37. Huisamen, B., Pêrel, S. J., Friedrich, S. O., Salie, R., Strijdom, H. and Lochner, A. (2011). ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance. Mol. Cell. Biochem. 349, 21-31.
38. Ji, L., Fu, F., Zhang, L., Liu, W., Cai, X., Zhang, L., Zheng, Q., Zhang, H. and Gao, F. (2010). Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am. J. Physiol. Endocrinol. Metab. 298, E871-E880.
39. Juhaszova, M., Zorov, D. B., Yaniv, Y., Nuss, H. B., Wang, S. and Sollott, S. J. (2009). Role of glycogen synthase kinase-3beta in cardioprotection. Circ. Res. 104, 1240-1252.
40. Katakam, P. V., Jordan, J. E., Snipes, J. A., Tulbert, C. D., Miller, A. W. and Busija, D. W. (2007). Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R920-R926. (Pubitemid 46207749)
41. Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B. and Vasan, R. S. (2002). Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305-313. (Pubitemid 34815352)
42. Kragelund, C., Hassager, C., Hildebrandt, P., Torp-Pedersenand C., Køber, L. (2005). Impact of obesity on long-term prognosis following acute myocardial infarction. Int. J. Cardiol. 98, 123-131. (Pubitemid 40169862)
43. Lauzier, B., Delemasure, S., Pesant, M., Collin, B., Duvillard, L., Vergely, C., Connat, J. L. and Rochette, L. (2009). A cholesterol-rich diet improves resistance to ischemic insult in mouse hearts but suppresses the beneficial effect of post-conditioning. J. Heart Lung Transplant. 28, 821-826.
44. Lavie, C. J., Milani, R. V. and Ventura, H. O. (2009). Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53, 1925-1932.
45. Lisa, M., Haleagrahara, N. and Chakravarthi, S. (2011). Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally-induced myocardial infarction in rats. Vasc. Cell 3, 13.
46. Maarman, G., Marais, E., Lochner, A. and Du Toit, E. F. (2012). Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity. Cardiovasc. Drugs Ther. 26, 205-216.
47. Marais, E., Genade, S., Salie, R., Huisamen, B., Maritz, S., Moolman, J. A. and Lochner, A. (2005). The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning. Basic Res. Cardiol. 100, 35-47. (Pubitemid 40069105)
48. Morel, S., Berthonneche, C., Tanguy, S., Toufektsian, M. C., Foulon, T., De Lorgeril, M., De Leiris, J. and Boucher, F. (2003). Insulin resistance modifies plasma fatty acid distribution and decreases cardiac tolerance to in vivo ischaemia/reperfusion in rats. Clin. Exp. Pharmacol. Physiol. 30, 446-451. (Pubitemid 36836559)
49. Moro, C., Grauzam, S., Ormezzano, O., Toufektsian, M. C., Tanguy, S., Calabrese, P., Coll, J. L., Bak, I., Juhasz, B., Tosaki, A. et al. (2011). Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction. J. Cell. Mol. Med. 15, 1688-1694.
50. Pagano, G., Cassader, M., Diana, A., Pisu, E., Bozzo, C., Ferrero, F. and Lenti, G. (1981). Insulin resistance in the aged: the role of the peripheral insulin receptors. Metabolism 30, 46-49. (Pubitemid 11104917)
51. Palanivel, R., Eguchi, M., Shuralyova, I., Coe, I. and Sweeney, G. (2006). Distinct effects of short-and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes. Metabolism 55, 1067-1075.
52. Peart, J. N. and Headrick, J. P. (2003). Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects. Cardiovasc. Res. 58, 589-601. (Pubitemid 36694445)
53. Peart, J. N., Gross, E. R., Headrick, J. P. and Gross, G. J. (2007). Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J. Mol. Cell. Cardiol. 42, 972-980. (Pubitemid 46678033)
54. Peterson, L. R., Waggoner, A. D., Schechtman, K. B., Meyer, T., Gropler, R. J., Barzilai, B. and Dávila-Román, V. G. (2004). Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J. Am. Coll. Cardiol. 43, 1399-1404. (Pubitemid 38496345)
55. Pingitore, A., Di Bella, G., Lombardi, M., Iervasi, G., Strata, E., Aquaro, G. D., Positano, V., De Marchi, D., Rossi, G., L'Abbate, A. et al. (2007). The obesity paradox and myocardial infarct size. J. Cardiovasc. Med. (Hagerstown) 8, 713-717. (Pubitemid 47282051)
56. Rana, J. S., Mukamal, K. J., Morgan, J. P., Muller, J. E. and Mittleman, M. A. (2004). Obesity and the risk of death after acute myocardial infarction. Am. Heart J. 147, 841-846. (Pubitemid 38880995)
57. Ren, J., Dong, F., Cai, G. J., Zhao, P., Nunn, J. M., Wold, L. E. and Pei, J. (2010). Interaction between age and obesity on cardiomyocyte contractile function: role of leptin and stress signaling. PLoS ONE 5, e10085.
58. Savage, D. B., Petersen, K. F. and Shulman, G. I. (2005). Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45, 828-833. (Pubitemid 40628921)
59. Schaffer, S. W., Croft, C. B. and Solodushko, V. (2000). Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am. J. Physiol. Heart Circ. Physiol. 278, H1948-H1954. (Pubitemid 30439208)
60. Schwarz, E. R., Somoano, Y., Hale, S. L. and Kloner, R. A. (2000). What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat? J. Thromb. Thrombolysis 10, 181-187.
61. Sharma, V., Mustafa, S., Patel, N., Wambolt, R., Allard, M. F. and McNeill, J. H. (2009). Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism. Eur. J. Pharmacol. 617, 113-117.
62. Shizukuda, Y., Reyland, M. E. and Buttrick, P. M. (2002). Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 282, H1625-H1634. (Pubitemid 34654828)
63. Smith, C. C. and Yellon, D. M. (2011). Adipocytokines, cardiovascular pathophysiology and myocardial protection. Pharmacol. Ther. 129, 206-219.
64. Smith, C. C., Mocanu, M. M., Davidson, S. M., Wynne, A. M., Simpkin, J. C. and Yellon, D. M. (2006). Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br. J. Pharmacol. 149, 5-13. (Pubitemid 44299063)
65. Stoddard, M. F., Tseuda, K., Thomas, M., Dillon, S. and Kupersmith, J. (1992). The influence of obesity on left ventricular filling and systolic function. Am. Heart J. 124, 694-699.
66. Szucs, G., Bester, D. J., Kupai, K., Csont, T., Csonka, C., Esterhuyse, A. J., Ferdinandy, P. and Van Rooyen, J. (2011). Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats. Lipids Health Dis. 10, 103.
67. Tsang, A., Hausenloy, D. J., Mocanu, M. M., Carr, R. D. and Yellon, D. M. (2005). Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 54, 2360-2364. (Pubitemid 41134263)
68. Wagner, C., Kloeting, I., Strasser, R. H. and Weinbrenner, C. (2008). Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J. Cardiovasc. Pharmacol. 52, 430-437.
69. Wilson, C. R., Tran, M. K., Salazar, K. L., Young, M. E. and Taegtmeyer, H. (2007). Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem. J. 406, 457-467. (Pubitemid 47425452)
70. Wong, C. Y., O'Moore-Sullivan, T., Leano, R., Byrne, N., Beller, E. and Marwick, T. H. (2004). Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110, 3081-3087. (Pubitemid 39492002)
71. Xu, G., Takashi, E., Kudo, M., Ishiwata, T. and Naito, Z. (2004). Contradictory effects of short-and long-term hyperglycemias on ischaemic injury of myocardium via intracellular signaling pathway. Exp. Mol. Pathol. 76, 57-65. (Pubitemid 38096320)
72. Yang, X. M., Krieg, T., Cui, L., Downey, J. M. and Cohen, M. V. (2004). NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J. Mol. Cell. Cardiol. 36, 411-421. (Pubitemid 38316946)
73. Yue, T. L., Bao, W., Gu, J. L., Cui, J., Tao, L., Ma, X. L., Ohlstein, E. H. and Jucker, B. M. (2005). Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury. Diabetes 54, 554-562.
74. Zarich, S. W., Kowalchuk, G. J., McGuire, M. P., Benotti, P. N., Mascioli, E. A. and Nesto, R. W. (1991). Left ventricular filling abnormalities in asymptomatic morbid obesity. Am. J. Cardiol. 68, 377-381.